This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Marian deMarinis, MD; Ernest N. Arnett, MD

Arch Intern Med. 1978;138(11):1732-1733.

Abstract
The Collaborative Study Group for the Study of Stroke in Young Women studied 598 women from age 15 to 44 years with cerebrovascular disease. They found that the use of oral contraceptives was significantly more prevalent in women who had suffered a thrombotic stroke than in women who had not had strokes. The risk of thrombotic stroke was estimated to be nine times greater in users of oral contraceptives than in nonusers. We report a case in which a previously healthy man who was using an oral contraceptive drug developed middle cerebral artery occlusion.

In the absence of other predisposing factors in this case, it appears that the cerebrovascular occlusion was related to estrogen administration. The occurrence of persistent severe headaches in patients using estrogenic hormones may be a clue to impending cerebrovascular occlusion.

(Arch Intern Med 138:1732-1733, 1978)

Author Affiliations
From the Department of Medicine, The Johns Hopkins Hospital and The Johns Hopkins University School of Medicine, Baltimore.

Footnotes
Accepted for publication June 7, 1978.

Reprint requests to 550 N Broadway, Baltimore, MD 21205 (Dr deMarinis).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?